Intro

This chapter delves into the FDA panel's recent rejection of MDMA-assisted psychotherapy for PTSD, highlighting a woman's transformative experience during the therapy. It contemplates the consequences of the FDA's decision and the challenges in accessing such therapy in the United States.

Transcript

Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.